Established in 1985, Anatrace has built the broadest portfolio of detergents and lipids available in the marketplace with a core competency of developing and manufacturing creative solutions for stabilizing and solubilizing macromolecules.

“Anatrace is a high quality company offering a value-add product that is mission critical to its customer base,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “We are confident that as a standalone company, Anatrace will continue to build on its tradition of collaborating with its global customer base to help answer critical questions in the advancement of important studies across multiple scientific fields including cancer research.”

“StoneCalibre has been a great partner for us through this process,” said Frank Witney, Chief Executive Officer of Affymetrix. “Their corporate carve-out experience and ability to offer speed and certainty around the sale process were critical factors for us. We feel that StoneCalibre will provide a great long-term home for Anatrace and its devoted employee base.”

Ben Travis, the newly appointed CEO of Anatrace, expressed his enthusiasm for partnering with StoneCalibre. “Anatrace’s passion for detergents and lipids, combined with StoneCalibre’s strategic and financial support, will help drive the company to higher levels of excellence and allow us to capitalize on future growth opportunities.”

Anatrace is StoneCalibre’s second acquisition in the last five months. The terms of the transaction were not disclosed. EMA Partners acted as the exclusive financial advisor to Affymetrix.